Febuxostat Does Not Increase All-Cause Mortality and Cardiovascular Mortality Compared With Placebo: Comment on the Article by Choi et al
- PMID: 30295433
- DOI: 10.1002/art.40744
Febuxostat Does Not Increase All-Cause Mortality and Cardiovascular Mortality Compared With Placebo: Comment on the Article by Choi et al
Comment in
-
Reply.Arthritis Rheumatol. 2019 Mar;71(3):481-482. doi: 10.1002/art.40742. Epub 2019 Feb 7. Arthritis Rheumatol. 2019. PMID: 30295436 No abstract available.
Comment on
-
New Perspectives in Rheumatology: Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial and the Associated Food and Drug Administration Public Safety Alert.Arthritis Rheumatol. 2018 Nov;70(11):1702-1709. doi: 10.1002/art.40583. Arthritis Rheumatol. 2018. PMID: 29869840 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
